Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anemia, Sickle Cell × voxelotor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Sickle Cell 1

Interventions

fludarabine phosphate 4 fludarabine 4 Cyclophosphamide 4 Thiotepa 3 Melphalan 3 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Fentanyl 2 Busulfan 2 Alemtuzumab 2 voxelotor 1 thymoglobulin 1 maltodextrin 1 Rituximab 1 Registries 1 Range of Motion, Articular 1 Protease Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Medical Marijuana 1 Interviews as Topic 1 Imagery, Psychotherapy 1 Holistic Health 1 Glutamine 1 Erythrocyte Count 1 Dexamethasone 1 Clofarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03036813 2023-07-27

GBT_HOPE

Pfizer

Phase 3 Completed

449 enrolled 17 charts 1 FDA

Classical hematology

Anemia, Sickle Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡